Your session is about to expire
← Back to Search
Percutaneous vs Surgical Mitral Valve Repair for Mitral Valve Regurgitation (REVIVE Trial)
REVIVE Trial Summary
This trial will help determine if percutaneous mitral valve repair is a viable treatment option for ischemic MR.
REVIVE Trial Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowREVIVE Trial Timeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.REVIVE Trial Design
Find a Location
Who is running the clinical trial?
Media Library
- My heart test shows reversible damage.My heart valve condition is due to a mix of causes like infection or tissue issues.I have severe heart valve leakage as per the 2017 guidelines.My heart valve's shape is not right for MitraClip treatment.I am under 18 years old.My doctors have advised against surgery for my heart condition due to high risks.I need surgery that is not for heart bypass, tricuspid valve repair, PFO closure, ASD closure, or the Maze procedure.My heart valve issue is due to a recent heart muscle injury.I have had surgery or a procedure to fix my mitral valve.
- Group 1: Percutaneous mitral repair
- Group 2: Mitral valve surgery
- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
How many participants are currently engaged in this research project?
"Affirmative. The information available on clinicaltrials.gov specifies that this medical trial began recruiting patients as of August 12, 2021 and the latest update was posted on November 14, 2022. To complete the study, 80 individuals need to be enrolled at a solitary site."
Are there any unfilled vacancies in this clinical trial?
"Affirmative. According to the details published on clinicaltrials.gov, this medical study is actively enlisting participants with a view of beginning trials in 2021 and concluding them towards the end of 2022. Remarkably, only 80 patients need to be recruited from one facility for these tests to commence."
Share this study with friends
Copy Link
Messenger